T1	Cluster6 0 11	Tauopathies
T2	Entity 78 94	the accumulation
T3	Entity 126 132	brains
T4	Cluster3 170 179	tauopathy
T5	Cluster4 360 372	the mutation
T6	Entity 373 382	corrected
T7	Cluster5 401 424	the homozygous mutation
T8	Entity 425 435	engineered
T9	Entity 516 533	neurodegeneration
T10	Entity 635 644	a patient
T11	Cluster4 650 659	TAU-A152T
T12	Entity 732 740	restored
T13	Entity 757 766	decreases
T14	Entity 862 869	neurons
T15	Cluster5 875 898	the homozygous mutation
T16	Cluster3 833 842	tauopathy
T17	Entity 98 122	pathological TAU protein
T18	Entity 326 349	two isogenic iPSC lines
T19	Entity 900 929	These isogenic TAU-iPSC lines
T20	Cluster6 1017 1028	tauopathies
T21	Cluster3 1168 1177	tauopathy
T22	Entity 1184 1199	TAU-A152T-iPSCs
T23	Cluster3 1246 1255	tauopathy
T24	Entity 1202 1212	Correction
T25	Entity 1258 1268	Engineered
T26	Cluster3 1311 1320	tauopathy
T27	Cluster3 1376 1385	tauopathy
T28	Entity 847 858	intensified
T29	Entity 1299 1310	intensifies
T30	Entity 1235 1245	eliminates
T31	Entity 996 1013	mechanistic study
T32	Entity 970 991	the accurate modeling
T33	Entity 22 60	a group of neurodegenerative disorders
T34	Entity 144 166	a human neuronal model
T35	Entity 193 231	induced pluripotent stem cells (iPSCs)
T36	Cluster4 241 261	a TAU-A152T mutation
T37	Entity 269 311	zinc-finger nuclease-mediated gene editing
T38	Cluster7 437 455	The A152T mutation
T39	Entity 466 503	TAU fragmentation and phosphorylation
T40	Entity 549 568	axonal degeneration
T41	Entity 570 595	These cellular phenotypes
T42	Entity 666 685	mutation correction
T43	Entity 687 726	normal neuronal and axonal morphologies
T44	Entity 770 807	TAU fragmentation and phosphorylation
T45	Entity 817 829	the severity
T46	Entity 1034 1047	human neurons
T47	Entity 1075 1097	drug-screening efforts
T48	Entity 1109 1129	cell-based therapies
T49	Entity 1144 1164	A human neuron model
T50	Cluster4 1216 1234	TAU-A152T mutation
T51	Entity 1269 1298	homozygous TAU-A152T mutation
T52	Cluster7 1323 1337	A152T mutation
T53	Entity 1348 1363	TAU proteolysis
T54	Entity 180 187	derived
T55	Entity 316 325	generated
T56	Entity 456 465	increased
T57	Entity 1338 1347	increases
T58	Cluster1 134 136	We
T59	Cluster1 313 315	we
T60	Cluster8 144 261	a human neuronal model of tauopathy derived from induced pluripotent stem cells (iPSCs) carrying a TAU-A152T mutation
T61	Cluster8 1144 1199	A human neuron model of tauopathy using TAU-A152T-iPSCs
